- Home
- NBIX vs UNM Comparison
NBIX vs UNM Comparison
Compare NBIX & UNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- UNM
- Stock Information
- Founded
- NBIX 1992
- UNM 1848
- Country
- NBIX United States
- UNM United States
- Employees
- NBIX N/A
- UNM N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- UNM Accident &Health Insurance
- Sector
- NBIX Health Care
- UNM Finance
- Exchange
- NBIX Nasdaq
- UNM Nasdaq
- Market Cap
- NBIX 12.4B
- UNM 14.4B
- IPO Year
- NBIX 1996
- UNM 1986
- Fundamental
- Price
- NBIX $134.33
- UNM $80.43
- Analyst Decision
- NBIX Strong Buy
- UNM Buy
- Analyst Count
- NBIX 21
- UNM 13
- Target Price
- NBIX $165.14
- UNM $88.69
- AVG Volume (30 Days)
- NBIX 821.3K
- UNM 1.4M
- Earning Date
- NBIX 07-30-2025
- UNM 07-29-2025
- Dividend Yield
- NBIX N/A
- UNM 2.10%
- EPS Growth
- NBIX N/A
- UNM 26.80
- EPS
- NBIX 2.96
- UNM 8.54
- Revenue
- NBIX $2,412,600,000.00
- UNM $12,778,600,000.00
- Revenue This Year
- NBIX $16.29
- UNM $4.35
- Revenue Next Year
- NBIX $15.08
- UNM $3.88
- P/E Ratio
- NBIX $45.11
- UNM $9.37
- Revenue Growth
- NBIX 21.73
- UNM 1.82
- 52 Week Low
- NBIX $84.23
- UNM $51.25
- 52 Week High
- NBIX $157.98
- UNM $84.48
- Technical
- Relative Strength Index (RSI)
- NBIX 70.92
- UNM 49.28
- Support Level
- NBIX $127.03
- UNM $79.05
- Resistance Level
- NBIX $135.94
- UNM $83.13
- Average True Range (ATR)
- NBIX 2.85
- UNM 1.50
- MACD
- NBIX 0.47
- UNM -0.01
- Stochastic Oscillator
- NBIX 87.52
- UNM 40.08
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About UNM Unum Group
Unum Group is a provider of group and individual income protection insurance products in the United States, the United Kingdom, Poland, and other countries. It is the domestic disability insurer, with the majority of premiums generated from employer plans. The company also offers a complementary portfolio of other insurance products, including long-term care insurance, life insurance, and employer- and employee-paid group benefits. It has the following operating business segments: Unum USA, Unum International, Closed Block, Colonial Life, and Corporate. The majority of the revenue is earned from the Unum USA segment. The firm markets its products through brokers.